DFine
DFine develops minimally invasive spinal intervention devices — including steerable balloon catheters, vertebral augmentation systems, and targeted radiofrequency ablation tools — for interventional radiologists and spine surgeons treating vertebral compression fractures and metastatic spinal tumors, distributed globally via Merit Medical's network in 40+ countries.
- Company typePublic
- Founded2004
- HeadquartersSan Jose, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What DFine does
DFine is a medical device company founded in 2004 and headquartered in San Jose, California, that develops minimally invasive therapeutic devices for spinal pathologies, with a primary focus on vertebral compression fractures (VCFs) and metastatic spinal tumors. The company's core technology portfolio centers on steerable balloon catheter systems and targeted radiofrequency ablation (t-RFA), including the Arcadia Next Generation Balloon Catheter, StabiliT MX and VP Vertebral Augmentation Systems, Osseoflex SB Steerable and Straight Balloons, and the STAR Tumor Ablation System. DFine also markets a bone biopsy product family (Huntington, Kensington, Madison, Madison Mini, Westbrook) for diagnostic sample extraction. The platform enables interventional radiologists and spine surgeons to achieve bipedicular-like cement distribution via a unipedicular approach, reducing tissue disruption and procedural complexity.
DFine's products are now distributed and manufactured through Merit Medical Systems' global commercial infrastructure, headquartered at 1600 West Merit Parkway, South Jordan, Utah. The company operates as a dedicated spinal intervention product line within Merit Medical, leveraging Merit's direct sales force and authorized distributor network spanning 40+ countries across Asia, Europe, the Middle East, Africa, North America, South America, and Oceania. The business model is hardware sales of disposable and durable medical devices sold to hospitals, spine surgery centers, and specialist physicians performing fluoroscopy-guided spinal procedures. Pricing is not publicly disclosed and is handled through standard healthcare provider procurement and distributor relationships. The company maintains ISO 13485 certification for medical device quality management and supports adoption through the Think Spine physician education program, which delivers credentialing courses, virtual training, recorded webinars, and product documentation.
Prior to its integration with Merit Medical, DFine raised approximately $129.8 million across multiple funding rounds from 2005 to 2012, with investors including Highland Capital Partners, OrbiMed, Prospect Venture Partners, Split Rock Partners, Sterling Capital Management, and Vanguard Ventures. Current headcount is 101-250 employees, and the company is led by founders Afser Shariff and Rodney Perkins, with Lewis Yee as CFO, Douglas M. Petty as SVP of Marketing, and Eric Schaber as VP of Operations, Europe.
DFine firmographics
Firmographics- Name
- DFine
- Legal name
- Merit Medical Systems, Inc.
- Website
- https://dfineinc.com
- Company type
- Public
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- DFine develops minimally invasive spinal intervention devices — including steerable balloon catheters, vertebral augmentation systems, and targeted radiofrequency ablation tools — for interventional radiologists and spine surgeons treating vertebral compression fractures and metastatic spinal tumors, distributed globally via Merit Medical's network in 40+ countries.
- Ownership category
- akta.pro rank
DFine industry classification
Industry- Product category
- Minimally Invasive Spinal Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)
- akta.pro secondary industry
- Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
Keywords
Where DFine is headquartered
LocationHeadquarters
- HQ city
- San Jose
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
DFine business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of spinal augmentation products including balloon catheters, vertebral augmentation systems, tumor ablation systems, and bone biopsy tools to healthcare providers
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
DFine product offering
Product offeringCore offering
DFine develops, manufactures, and sells minimally invasive medical devices for treating vertebral compression fractures (VCFs), metastatic spinal tumors, and bone biopsy procedures. The portfolio includes steerable balloon-assisted vertebral augmentation catheters, high-viscosity cement delivery systems, targeted radiofrequency ablation systems, and bone biopsy kits, sold to hospitals and spine specialists worldwide through Merit Medical's distribution network.
Product overview
Merit Medical offers a comprehensive portfolio of spine treatment solutions centered on next-generation steerable technologies. The product suite comprises Spinal Augmentation systems including Arcadia™ Next Generation Balloon Catheter, StabiliT® MX Vertebral Augmentation System, StabiliT® VP Vertebroplasty System, and Osseoflex® SB Steerable and Straight Balloons; Advanced Energy products featuring the STAR™ Tumor Ablation System for targeted radiofrequency ablation; and Bone Biopsy solutions including Huntington, Kensington, Madison, Madison Mini, and Westbrook systems. These sophisticated steerable technologies enable clinicians to achieve bipedicular-like cement distribution using unipedicular approaches, improving procedural efficiency while minimizing tissue disruption for vertebral compression fracture treatment and spinal tumor ablation.
Differentiator
Problem solved
Functional benefit
Brands
- Merit OEM: OEM solutions division
- Merit Sensor
- Arcadia
- StabiliT
- Osseoflex
- STAR Tumor Ablation
- Think Spine
Products and services
- Arcadia Next Generation Balloon Catheter Steerable and straight balloon-assisted vertebral augmentation catheter designed to achieve controlled, precise, targeted cavity creation in vertebral augmentation procedures for interventional radiologists and spine surgeons.
- StabiliT MX Vertebral Augmentation System Steerable vertebral augmentation system providing controllability, dexterity, and control for preferential path creation and controlled delivery of high-viscosity cement across various fracture morphologies.
- StabiliT VP Vertebroplasty System Vertebroplasty system combining patented simple cement preparation with controlled delivery of high-viscosity cement for the treatment of vertebral compression fractures.
- StabiliT Vertebral Augmentation System Vertebral augmentation system combining a targeted approach with ultra-high viscosity cement to treat pathological fractures and minimize extravasation in the vertebrae.
- Osseoflex SB Steerable and Straight Balloons Inflatable bone tamps utilizing unipedicular or bipedicular approach to create a cavity by compacting cancellous bone for the treatment of vertebral compression fractures.
- STAR Tumor Ablation System Targeted radiofrequency ablation (t-RFA) system delivering meaningful pain relief and localized tumor destruction in a single treatment for metastatic spinal tumors, compatible with systemic therapies.
- Huntington Bone Biopsy System Guided perforating bone biopsy system for removing bone samples to detect cancer or abnormal cells in diagnostic procedures.
- Kensington Bone Biopsy System Guide wire bone biopsy system for extracting bone samples for diagnostic analysis.
- Madison Bone Biopsy System Perforating bone biopsy kit for bone sample extraction and diagnostic purposes.
- Madison Mini Bone Biopsy System Mini small bone biopsy system designed for minimally invasive bone sample collection.
- Westbrook Bone Biopsy System Basic bone biopsy system for extracting bone tissue samples for pathological examination.
Quantifiable outcome
- Bipedicular-like cement distribution using unipedicular approach
- +1 more outcomes
Companies that use DFine
Customer profileSegments2 records
Ideal customer profiles1 record
DFine technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
DFine partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
DFine competitors and assessment
Company assessmentBroad incumbents
- DePuy Synthes (Johnson & Johnson): J&J's orthopedic/spine franchise offers vertebral augmentation products and competes with DFine for spine specialist and hospital accounts globally.
- Stryker: Major diversified medtech player whose spine and interventional divisions compete in vertebral augmentation and adjacent spinal procedures, with comparable distribution scale to Merit Medical.
- Medtronic: Global medical device leader offering the KYPHON line of balloon kyphoplasty products that directly compete with DFine's StabiliT and Arcadia systems for vertebral compression fracture treatment.
- CareFusion (BD): Large medical technology company with spinal intervention and procedural device offerings; overlaps with DFine in bone biopsy and vertebral augmentation adjacencies.
Direct peers
- Vexim (Stryker Spine): Specialist in vertebral compression fracture treatment (SpineJack) acquired by Stryker; competes directly with DFine's vertebral augmentation portfolio in Europe and other markets.
- Alphatec Spine: Spine-focused medical device company developing and commercializing products for spine surgeons and interventionalists, addressing overlapping procedural categories with DFine.
- Globus Medical: Specialized spine device company offering vertebral augmentation and a broad spine portfolio, competing head-to-head with DFine in VCF and adjacent spinal intervention procedures.
- NuVasive (now Globus): Spine-focused medical device company with vertebral compression fracture and minimally invasive spine solutions that overlap with DFine's product portfolio and target specialists.
- Orthofix Medical: Spine and orthopedic device company with a vertebral augmentation/VCF franchise that competes directly with DFine's StabiliT and Arcadia systems.
Regional players
- SI-BONE: Spine-focused medical device company addressing specific spinal pathologies with minimally invasive solutions, comparable to DFine in clinical approach and specialist target market.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
DFine social profiles
Digital presenceDFine compliance and trust
Trust signalCompliance1 record
DFine financial estimates
Financial estimateRevenue estimate
Valuation estimate
DFine leadership team
Management profileNumber of profiles
Profiles5 records
DFine funding detail
Funding detailFunding overview
Funding rounds8 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DFine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DFine
What does DFine do?
DFine develops, manufactures, and sells minimally invasive medical devices for treating vertebral compression fractures (VCFs), metastatic spinal tumors, and bone biopsy procedures. The portfolio includes steerable balloon-assisted vertebral augmentation catheters, high-viscosity cement delivery systems, targeted radiofrequency ablation systems, and bone biopsy kits, sold to hospitals and spine specialists worldwide through Merit Medical's distribution network.
Is DFine a public or private company?
DFine is a public company. It is classified as corporate owned and is currently operating.
When was DFine founded?
DFine was founded in 2004. It employs 101 to 250 people.
Where is DFine based?
DFine is headquartered in San Jose, United States, in the North America region.
How does DFine make money?
One revenue line is on record: medical Device Sales.
Who are DFine's main competitors?
Broad incumbents on record are DePuy Synthes (Johnson & Johnson), Stryker, Medtronic and CareFusion (BD). Direct peers are Vexim (Stryker Spine), Alphatec Spine, Globus Medical, NuVasive (now Globus) and Orthofix Medical. SI-BONE is listed as a regional player.
Does DFine have an API?
No public API is recorded for DFine.
What industry is DFine in?
DFine's product category is Minimally Invasive Spinal Medical Devices. Its primary akta.pro industry code is HLAHAEAC, Spine Implants & Motion Preservation (Fusion/Disc/Interspinous), with a secondary code of HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339113 and its SIC code is 3841.